title: Does treatment of predialysis patients with recombinant human erythropoietin compromise renal function?
authors.affiliation: Department of Medicine, University Hospital, Nijmegen, The Netherlands.
authors.forename: R A
authors.initials: RA
authors.lastname: Koene
authors.forename: L A
authors.initials: LA
authors.lastname: Frenken
mesh_terms: D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007668:Kidney / Q000503:physiopathology*; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin